Google
×
Including results for acxp investor relations
Search only for aqxp investor relations
Mar 18, 2024 · Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success. View ...
Missing: aqxp | Show results with:aqxp
Investor Tools. Email Alerts · Contacts · RSS News Feed. News / Events. Overview ... Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 ...
Missing: aqxp | Show results with:aqxp
Associate Director, Investor Relations. Aquinox Pharmaceuticals, Inc. 604.901.3019. ir@aqxpharma.com. Bill Kadel. Vice President. Solebury Trout. 646.378.2934.
Summary of Income Statement, Balance Sheet, Cash Flow and Valuation Measures for Aquinox Pharmaceuticals AQXP.
Investor Relations. April 19, 202408:30 AM. Q1 2024 American Express Earnings ... Investor Relations. (212) 640-5574. IR@aexp.com. Transfer Agent. Computershare
Missing: aqxp | Show results with:aqxp
... stock. Our common stock is listed on The NASDAQ Global Market under the symbol “AQXP.” There can be no assurance that any selling stockholder will sell any.
Investors: Brendan Payne. Associate Director, Investor Relations. Aquinox Pharmaceuticals, Inc. 604.901.3019. ir@aqxpharma.com. Media: Lisa Guiterman.
Explore Investor Relations information for Aquis shareholders. View Aquis Share Price, annual reports, announcements, board information and more.
Jan 10, 2017 · Investors certainly have to be happy with Aquinox Pharmaceuticals, Inc. AQXP and its short term performance. After all, the stock has jumped ...
Radient hedge fund analytics simplifies hedge fund selection and evaluation for investors, allocators, and advisers.